What is the benefit of continuous glucose monitors (CGMs) for the treatment of type 1 diabetes mellitus (DM)?

Updated: Oct 08, 2021
  • Author: Romesh Khardori, MD, PhD, FACP; Chief Editor: George T Griffing, MD  more...
  • Print

Use of CGMs may help to prevent significant glucose variability in patients receiving either multiple daily injection therapy or continuous insulin infusion therapy. [118] Additionally, continuous glucose monitoring is associated with reduced time spent in hypoglycemia. [119] Whether glucose variability is detrimental in the absence of hypoglycemia remains an unresolved question; in any event, variability leads to the expense of frequent testing.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!